Clinical analysis of limited endoscopic sphincterotomy combined with endoscopic papillary bal-loon dilatation for the treatment of common duct stones
Nan-nan ZHANG,Ke-wei LI,Xi-wen ZHANG,Jun DING,Hao JIANG,Fu LI
DOI: https://doi.org/10.11952/j.issn.1007-1954.2017.01.004
2017-01-01
Abstract:objective To study the effects of endoscopic sphincterotomy (EST), endoscopic papilla balloon dilatation (EPBD) and limited endoscopic sphincterotomy combined with endoscopic papilla balloon dilatation (LEST+EPBD) on common bile duct stones. Methods A total of 398 patients with common duct stones treated in Renji Hospital from Jul. 2011 to Jul. 2014 were divided into three groups: endoscopic sphincterotomy group (EST group, n=228), endoscopic papilla balloon dilatation group (EPBD group, n=36) and limited endoscopic sphincterotomy combined with endoscopic papilla balloon dilatation group (LEST+EPBD group, n=134). The differences of stones diameter, success rate of stone removal, hospitalization stays, total expenses, the average maximum diameter of single stones, postoperative short-term (within 24 h) analysis of blood amylase changes, the short-term (within 1 week postoperation) complications such as pancreatitis, bleeding, perforation, biliary tract infection and long-term (within 2 years) complications such as reflux cholangitis, stones recurrence, were compared among three groups. Results There were no significant difference in gender composition, age, hos-pitalization stays and stone removal rates among three groups (P>0.05). Compared with the EST group, there were higher hospitalization expenses in EPBD group and LEST+EPBD group, and highest in LEST+EPBD group (P<0.05). Compared with the EST group and the EPBD group, the average maximum diameter of stones in LEST+EPBD group was biggest (P<0.05). For short-term complications, EPBD group had the highest incidence of pancreatitis among three groups (P<0.05); there was no significant difference in hyperamylasemia, bleeding, perforation and biliary tract infection among three groups (P>0.05). For long-term complications, there was no significant difference in reflux cholangitis among three groups (P>0.05), but LEST+EPBD group had lower stone recurrence rate than that in EST group (P<0.05). Conclusion LEST+EPBD is safer and more effective for com-mon bile duct stones than EST or EPBD treatment. Therefore, LEST+EPBD is worthy of clinical application.